Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis.

Arthritis, Psoriatic Arthritis, Rheumatoid Autoimmunity

Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
14 Jun 2022
Historique:
received: 27 10 2021
accepted: 12 05 2022
entrez: 14 6 2022
pubmed: 15 6 2022
medline: 15 6 2022
Statut: aheadofprint

Résumé

Immune and stromal cell communication is central in the pathogenesis of rheumatoid arthritis (RA) and psoriatic arthritis (PsA), however, the nature of these interactions in the synovial pathology of the two pathotypes can differ. Identifying immune-stromal cell crosstalk at the site of inflammation in RA and PsA is challenging. This study creates the first global transcriptomic analysis of the RA and PsA inflamed joint and investigates immune-stromal cell interactions in the pathogenesis of synovial inflammation. Single cell transcriptomic profiling of 178 000 synovial tissue cells from five patients with PsA and four patients with RA, importantly, without prior sorting of immune and stromal cells. This approach enabled the transcriptomic analysis of the intact synovial tissue and identification of immune and stromal cell interactions. State of the art data integration and annotation techniques identified and characterised 18 stromal and 14 immune cell clusters. Global transcriptomic analysis of synovial cell subsets identifies actively proliferating synovial T cells and indicates that due to differential λ and κ immunoglobulin light chain usage, synovial plasma cells are potentially not derived from the local memory B cell pool. Importantly, we report distinct fibroblast and endothelial cell transcriptomes indicating abundant subpopulations in RA and PsA characterised by differential transcription factor usage. Using receptor-ligand interactions and downstream target characterisation, we identify RA-specific synovial T cell-derived transforming growth factor (TGF)-β and macrophage interleukin (IL)-1β synergy in driving the transcriptional profile of FAPα

Identifiants

pubmed: 35701153
pii: annrheumdis-2021-221761
doi: 10.1136/annrheumdis-2021-221761
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Achilleas Floudas (A)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Conor M Smith (CM)

Translational Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Orla Tynan (O)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Nuno Neto (N)

Department of Mechanical and Manufacturing Engineering, Trinity College Dublin, Dublin, Ireland.

Vinod Krishna (V)

Immunology, Janssen Research & Development, Spring House, PA, USA.

Sarah M Wade (SM)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Megan Hanlon (M)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Clare Cunningham (C)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Viviana Marzaioli (V)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Mary Canavan (M)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Jean M Fletcher (JM)

Translational Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Ronan H Mullan (RH)

Department of Rheumatology, Tallaght University Hospital, Trinity College Dublin, Dublin, Ireland.

Suzanne Cole (S)

Immunology, Janssen Research & Development, Spring House, PA, USA.

Ling-Yang Hao (LY)

Immunology, Janssen Research & Development, Spring House, PA, USA.

Michael G Monaghan (MG)

Department of Mechanical and Manufacturing Engineering, Trinity College Dublin, Dublin, Ireland.

Sunil Nagpal (S)

Immunology, Janssen Research & Development, Spring House, PA, USA.

Douglas J Veale (DJ)

Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Ursula Fearon (U)

Molecular Rheumatology, Clinical Medicine, Trinity Biomedical Science Institute, Dublin, Ireland Fearonu@tcd.ie.
Eular Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, Univeristy College Dublin, Dublin, Ireland.

Classifications MeSH